<DOC>
	<DOCNO>NCT02581917</DOCNO>
	<brief_summary>This research trial study metabolic change blood sample patient acute myeloid leukemia . Studying sample blood patient acute myeloid leukemia laboratory may help doctor learn cancer development drug resistance .</brief_summary>
	<brief_title>Metabolic Changes Blood Samples From Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine metabolic adaptation occur follow exposure standard chemotherapeutic agent use peripheral blood mononuclear cell acute myeloid leukemia ( AML ) patient . OUTLINE : Patients undergo collection peripheral blood mononuclear cell ( PBMC ) sample analysis via cell isolation , glycolytic flux oxygen consumption assay , viability assay , western blot baseline , 24 , 48 , 72 hour start chemotherapy .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Patients schedule initiate chemotherapy either initial diagnosis AML relapse AML Total white blood cell count &gt; 1000/mcl AND &gt; = 50 % leukemic cell peripheral blood , determine automate differential Only patient start initial induction phase therapy eligible Patients already receive 1 dos chemotherapy present diagnosis exclude Prior exposure hydroxyurea acceptable must note time sample collection Patients must ability understand willingness sign institutional review board ( IRB ) approve informed consent document order participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>